Noncanonical NF-κB pathway driven inflammation across multiple cellular compartments identifies NIK as a therapeutic target for inflammatory bowel disease - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Targeting NIK in the Noncanonical NF-κB Pathway Reveals Inflammatory Mechanisms in Diverse Cellular Compartments Relevant to Inflammatory Bowel Disease

  • By

  • Hao Xu

  • Dun Li

  • Jie Liang

  • Nathan Adamson

  • Alexis Scherl

  • Luli Zou

  • Crystal Hu

  • Elaine E. Storm

  • Christian B. Cox

  • Adam Johnson

  • Mary E. Keir

  • Hua Zhang

  • Saiyu Hang

  • June 9, 2026

Share

Original Source(s)

Noncanonical NF-κB pathway driven inflammation across multiple cellular compartments identifies NIK as a therapeutic target for inflammatory bowel disease

  • by Hao Xu, Dun Li, Jie Liang, Nathan Adamson, Alexis Scherl, Luli Zou, Crystal Hu, Elaine E. Storm, Christian B. Cox, Adam Johnson, Mary E. Keir, Hua Zhang, Saiyu Hang

  • June 9, 2026

Related Content

Long-term classification stability and treatment patterns of inflammatory bowel disease unclassified: a longitudinal observational study

Prenatal Exposure to Acid-Suppressive Medications and Incident Risk of Inflammatory Bowel Disease in Children

Risk of Infections With Infliximab vs Adalimumab Among Children With Inflammatory Bowel Disease